Baroreflex Stimulation Devices
Customize your policy alerts
Sign up for healthspring Policy THE801.034 alerts
Get alerted when Policy THE801.034 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage of baroreflex stimulation therapy using implanted devices for heart failure and other indications. It applies to providers seeking coverage for individuals considered for this therapy.
A new medical policy establishes that FDA-approved baroreflex stimulation therapy is experimental, investigational, and/or unproven for heart failure and all other indications.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.